“…Severe dry eye, ocular surface inflammation, and persistent epithelial defect have all been identified as risk factors. 8,[12][13][14][15] Exposure to medications has also been implicated, including the preservatives phenylmercuric nitrate 29,30 and thiomersal, 12 retinoic acid, 15 dexamethasone, 17 and timolol. 18 The presence of phosphate, either as part of the active agent or as the buffer system, has been a common feature in some series in which topical treatment is used 11,[17][18][19] or when it was injected intraocularly with viscoelastic.…”